These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22026157)

  • 1. Generation of a liver targeting fusion interferon and its bioactivity analysis in vitro.
    Cai G; Jiang M; Zhou Y; Gu X; Zhang B; Zou M; Zhou X; Bao J; Cao G; Zhang R
    Pharmazie; 2011 Oct; 66(10):761-5. PubMed ID: 22026157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
    Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
    Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of extracts from Radix Trichosanthis on the expression of HBsAg and HBeAg in HepG2.2.15 cells].
    Chen J; Xu Z; Ouyang H; Peng M; Wu T; Liu J; Liu Y; Yan H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):38-41. PubMed ID: 22349378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
    Huang YQ; Wang LW; Yan SN; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
    Yan SN; Deng B; Gong ZJ
    Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
    Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
    Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C.
    Wang XY; Crowston JG; Zoellner H; Healey PR
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3655-61. PubMed ID: 17652735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
    Yingkun N; Lvsong Z; Huimin Y
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of inhibiting proliferation and inducing apoptosis of human gastric cancer cell line SGC7901 by ursolic acid].
    Zhang YY; Deng T; Hu ZF; Zhang QP; Zhang J; Jiang H
    Ai Zheng; 2006 Apr; 25(4):432-7. PubMed ID: 16613675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
    Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
    Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
    Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
    Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
    Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing the pharmacokinetics and pharmacodynamics of interferon-α2b and human serum albumin fusion protein by proteolytic or reductive cleavage increases its in vivo therapeutic efficacy.
    Zhao HL; Xue C; Du JL; Ren M; Xia S; Liu ZM
    Mol Pharm; 2012 Mar; 9(3):664-70. PubMed ID: 22224503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of inhibition effect of bovine lactoferrin in vitro on hepatitis B surface antigen].
    Li S; Huang G; Zhou H; Liu N
    Wei Sheng Yan Jiu; 2008 Mar; 37(2):196-8. PubMed ID: 18589607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of nosiheptide liposomes and its inhibitory effect on hepatitics B virus in vitro].
    Cai QS; Huang H; Feng MQ; Zhou P
    Yao Xue Xue Bao; 2005 May; 40(5):462-5. PubMed ID: 16220794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.